• Je něco špatně v tomto záznamu ?

Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer

D. Vrana, M. Matzenauer, R. Aujesky, R. Vrba, C. Neoral, B. Melichar, P. Souček,

. 2017 ; 37 (2) : 403-412.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013267

Esophageal cancer is a disease with disappointing prognosis. Currently, there are no predictive factors that can identify patients who on the one hand would likely benefit from tri-modality management and, on the other hand, would not be significantly affected by the morbidity accompanying the treatment. MicroRNAs are short non-coding RNAs responsible for post-transcriptional modification of gene expression by binding to 3'-UTR of messenger RNA and represent emerging potential predictive biomarkers of treatment (chemotherapy and radiotherapy) efficacy and toxicity. We reviewed the current literature, addressing the potential predictive role of microRNAs for efficacy of chemotherapy (specifically cisplatin, 5-fluorouracil, doxorubicin and paclitaxel) and radiotherapy, including predicted targets in the cell. Altogether 82 articles were identified and included in this review. This may be the first review on this topic specifically focusing on neoadjuvant treatment of esophageal cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013267
003      
CZ-PrNML
005      
20170418114041.0
007      
ta
008      
170413s2017 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.11332 $2 doi
035    __
$a (PubMed)28179285
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Vrana, David $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, University Hospital in Olomouc, Olomouc, Czech Republic.
245    10
$a Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer / $c D. Vrana, M. Matzenauer, R. Aujesky, R. Vrba, C. Neoral, B. Melichar, P. Souček,
520    9_
$a Esophageal cancer is a disease with disappointing prognosis. Currently, there are no predictive factors that can identify patients who on the one hand would likely benefit from tri-modality management and, on the other hand, would not be significantly affected by the morbidity accompanying the treatment. MicroRNAs are short non-coding RNAs responsible for post-transcriptional modification of gene expression by binding to 3'-UTR of messenger RNA and represent emerging potential predictive biomarkers of treatment (chemotherapy and radiotherapy) efficacy and toxicity. We reviewed the current literature, addressing the potential predictive role of microRNAs for efficacy of chemotherapy (specifically cisplatin, 5-fluorouracil, doxorubicin and paclitaxel) and radiotherapy, including predicted targets in the cell. Altogether 82 articles were identified and included in this review. This may be the first review on this topic specifically focusing on neoadjuvant treatment of esophageal cancer.
650    _2
$a adjuvantní chemoradioterapie $7 D059186
650    _2
$a nádory jícnu $x genetika $x terapie $7 D004938
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x biosyntéza $x genetika $7 D035683
650    _2
$a neoadjuvantní terapie $7 D020360
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Matzenauer, Marcel $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic mmatzenauer@me.com.
700    1_
$a Aujesky, Rene $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. $7 gn_A_00010095
700    1_
$a Vrba, Radek $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Neoral, Cestmir $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Melichar, Bohuslav $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, University Hospital in Olomouc, Olomouc, Czech Republic.
700    1_
$a Souček, Pavel $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 37, č. 2 (2017), s. 403-412
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28179285 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418114349 $b ABA008
999    __
$a ok $b bmc $g 1199732 $s 974045
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 37 $c 2 $d 403-412 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Možnosti archivace